Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies

Natural polysaccharides have received a lot of attention in the biomedical field. Indeed, sources of polysaccharides, extracted or produced from plants, bacteria, fungi or algae, are diverse and renewable. Moreover, recent progresses in polysaccharide chemistry and nanotechnologies allow elaborating...

Full description

Bibliographic Details
Main Authors:	Silva, Amanda Karine Andriola, Letourneur, Didier, Chauvierre, Cédric
Format:	Online
Language:	English
Published:	Ivyspring International Publisher 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982129/

id	pubmed-3982129
recordtype	oai_dc
spelling	pubmed-39821292014-04-10 Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies Silva, Amanda Karine Andriola Letourneur, Didier Chauvierre, Cédric Review Natural polysaccharides have received a lot of attention in the biomedical field. Indeed, sources of polysaccharides, extracted or produced from plants, bacteria, fungi or algae, are diverse and renewable. Moreover, recent progresses in polysaccharide chemistry and nanotechnologies allow elaborating new dedicated nanosystems. Polysaccharide-based nanosystems may be designed for interacting in several biological processes. In particular, the atherothrombotic pathology is highly concerned by polysaccharide-mediated recognition. Atherothrombotic diseases, regardless of the anatomical localization, remain the main causes of morbidity and mortality in the industrialized world. This review intends to provide an overview on polysaccharide-based nanosystems as drug delivery systems and targeted contrast agents for molecular imaging with an emphasis on the treatment and imaging of cardiovascular pathologies. Ivyspring International Publisher 2014-03-11 /pmc/articles/PMC3982129/ /pubmed/24723980 http://dx.doi.org/10.7150/thno.7688 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Silva, Amanda Karine Andriola Letourneur, Didier Chauvierre, Cédric
spellingShingle	Silva, Amanda Karine Andriola Letourneur, Didier Chauvierre, Cédric Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
author_facet	Silva, Amanda Karine Andriola Letourneur, Didier Chauvierre, Cédric
author_sort	Silva, Amanda Karine Andriola
title	Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
title_short	Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
title_full	Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
title_fullStr	Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
title_full_unstemmed	Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
title_sort	polysaccharide nanosystems for future progress in cardiovascular pathologies
description	Natural polysaccharides have received a lot of attention in the biomedical field. Indeed, sources of polysaccharides, extracted or produced from plants, bacteria, fungi or algae, are diverse and renewable. Moreover, recent progresses in polysaccharide chemistry and nanotechnologies allow elaborating new dedicated nanosystems. Polysaccharide-based nanosystems may be designed for interacting in several biological processes. In particular, the atherothrombotic pathology is highly concerned by polysaccharide-mediated recognition. Atherothrombotic diseases, regardless of the anatomical localization, remain the main causes of morbidity and mortality in the industrialized world. This review intends to provide an overview on polysaccharide-based nanosystems as drug delivery systems and targeted contrast agents for molecular imaging with an emphasis on the treatment and imaging of cardiovascular pathologies.
publisher	Ivyspring International Publisher
publishDate	2014
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982129/
_version_	1612076563938934784

Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies

Similar Items